Nitroxoline
Nitroxoline (8-Hydroxy-5-nitroquinoline), an antibiotic, is an orally active antibiofilm agent. Nitroxoline reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Nitroxoline can be used for the urinary tract infections and cancer research[1][2][3].
Product Specifications
CAS Number
4008-48-4
Product Name Alternative
8-Hydroxy-5-nitroquinoline; 5-Nitro-8-quinolinol
UNSPSC
12352005
Hazard Statement
H301+H311+H331, H315, H319, H335
Target
Antibiotic; Apoptosis; Autophagy; Bacterial
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis; Autophagy
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/Nitroxoline.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC1=C2N=CC=CC2=C([N+]([O-])=O)C=C1
Molecular Formula
C9H6N2O3
Molecular Weight
190.16
Precautions
H301+H311+H331, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Thermococcus sibiricus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Recombinant Thermococcus sibiricus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Recombinant Thermococcus sibiricus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Recombinant Thermococcus sibiricus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Recombinant Thermococcus sibiricus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)